HI
LLY icon

Human Investing’s Eli Lilly LLY Stock Holding History

Human Investing’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Sell
2,265
-59
-3% -$60.3K 0.35% 26
2026
Q1 		$2.14M Buy
2,324
+17
+0.7% +$17.2K 0.31% 27
2025
Q4 		$2.48M Sell
2,307
-13
-0.6% -$12.4K 0.35% 26
2025
Q3 		$1.77M Sell
2,320
-5
-0.2% -$3.72K 0.26% 29
2025
Q2 		$1.81M Buy
2,325
+2
+0.1% +$1.55K 0.29% 29
2025
Q1 		$1.92M Hold
2,323
– – 0.34% 28
2024
Q4 		$1.79M Sell
2,323
-365
-14% -$302K 0.32% 29
2024
Q3 		$2.38M Sell
2,688
-74
-3% -$66.5K 0.43% 29
2024
Q2 		$2.5M Buy
2,762
+2
+0.1% +$1.6K 0.49% 27
2024
Q1 		$2.15M Sell
2,760
-23
-0.8% -$16.4K 0.43% 30
2023
Q4 		$1.62M Sell
2,783
-365
-12% -$213K 0.35% 30
2023
Q3 		$1.69M Sell
3,148
-63
-2% -$32.5K 0.39% 31
2023
Q2 		$1.51M Sell
3,211
-179
-5% -$75.1K 0.34% 30
2023
Q1 		$1.16M Sell
3,390
-110
-3% -$37.1K 0.28% 36
2022
Q4 		$1.28M Sell
3,500
-1,178
-25% -$418K 0.33% 35
2022
Q3 		$1.51M Sell
4,678
-119
-2% -$37.7K 0.39% 37
2022
Q2 		$1.55M Sell
4,797
-314
-6% -$94.3K 0.38% 38
2022
Q1 		$1.46M Buy
+5,111
New +$1.32M 0.32% 44
2021
Q4 		– Sell
-5,554
Closed -$1.28M – 96
2021
Q3 		$1.28M Sell
5,554
-1,289
-19% -$318K 0.3% 47
2021
Q2 		$1.57M Sell
6,843
-301
-4% -$60.5K 0.38% 41
2021
Q1 		$1.33M Sell
7,144
-1,378
-16% -$270K 0.34% 45
2020
Q4 		$1.44M Sell
8,522
-136
-2% -$20.3K 0.41% 41
2020
Q3 		$1.28M Sell
8,658
-5,478
-39% -$848K 0.42% 58
2020
Q2 		$2.32M Sell
14,136
-1,681
-11% -$258K 0.82% 23
2020
Q1 		$2.19M Buy
15,817
+3,527
+29% +$485K 0.95% 16
2019
Q4 		$1.61M Buy
12,290
+138
+1% +$16K 0.53% 52
2019
Q3 		$1.36M Sell
12,152
-216
-2% -$24K 0.48% 65
2019
Q2 		$1.37M Sell
12,368
-515
-4% -$60.6K 0.5% 64
2019
Q1 		$1.67M Sell
12,883
-12,901
-50% -$1.57M 0.62% 46
2018
Q4 		$2.98M Buy
+25,784
New +$2.88M 1.24% 13

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Human Investing's LLY Position: Q2 2026 in Review

Human Investing reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $60.3K and leaving 2,265 shares worth $2.72M. The position accounts for 0.35% of the portfolio, ranked #26.

Human Investing first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.98M in Q4 2018. 2,259 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Human Investing held 2,265 shares of Eli Lilly worth $2.72M as of Q2 2026.
  • Human Investing sold 59 Eli Lilly shares in Q2 2026, an estimated $60.3K.
  • Eli Lilly made up 0.35% of Human Investing's portfolio in Q2 2026, its #26 holding.
  • Human Investing first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Human Investing's Eli Lilly position peaked at $2.98M in Q4 2018.
  • 2,259 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.